Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this post-marketing surveillance study is to collect and assess information on safety and efficacy of valaciclovir in pediatric patients with chickenpox

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Acyclovir; Valacyclovir

Criteria

Inclusion Criteria:

• Pediatric patients with chickenpox (aged less than 15 years old).

Exclusion Criteria:

• Patients with a history of hypersensitivity to the ingredients of valaciclovir or acyclovir.